Home/ Stocks/ CLNN

Clene Inc. Common Stock

CLNN XNAS

$6.40 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$75.38M

About Clene Inc. Common Stock

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 79 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$15.0K	$-8,777,000	$-0.85
Q2 2025	$27.0K	$-7,419,000	$-0.78
Q1 2025	$81.0K	$-751,000	$-0.09
FY 2024	$342.0K	$-39,400,000	$-5.67

Related Market News

No specific coverage for CLNN yet. Check out our latest market news or earnings calendar.

Get CLNN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Clene Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.